About
Frequently Asked Questions
What is Ceregene?
Ceregene is an independent informational resource dedicated to the science of gene therapy and neurotrophic factor research. We aggregate, analyze, and present peer-reviewed findings in neurodegenerative disease therapeutics, with particular emphasis on adeno-associated virus (AAV) vector-mediated gene delivery and neurotrophic factor biology. This site operates independently and is not affiliated with, endorsed by, or representative of any pharmaceutical company, biotechnology firm, or clinical research organization.
Who maintains this site?
This resource is maintained by a small editorial team with backgrounds in molecular neuroscience, clinical pharmacology, and science communication. Our contributors hold advanced degrees in relevant biomedical disciplines and have collective experience spanning academic research, peer-reviewed publication, and medical writing. All content undergoes internal review for scientific accuracy prior to publication.
Why does this site exist?
The field of neurotrophic factor-based gene therapy has generated a substantial and rapidly evolving body of literature. Ceregene was established to serve as a centralized, accessible reference point for researchers, clinicians, patients, and science-literate readers seeking rigorous, clearly presented information on this therapeutic domain. We identified a gap between dense primary literature and oversimplified popular reporting — this site aims to bridge that gap with precision and clarity.
What topics does this site cover?
Our scope encompasses the following areas:
- Neurotrophic factors (NGF, GDNF, neurturin, CNTF, BDNF) and their therapeutic applications
- AAV-mediated gene delivery systems and vector engineering
- Neurodegenerative disease pathophysiology, including Alzheimer’s disease, Parkinson’s disease, ALS, and retinal degenerative conditions
- Preclinical and clinical trial data for gene therapy candidates
- Regulatory developments and translational research milestones
Is the information on this site medical advice?
No. The content presented on Ceregene is intended strictly for educational and informational purposes. It does not constitute medical advice, diagnosis, or treatment recommendations. Clinical decision-making should always involve consultation with qualified healthcare professionals who have access to complete patient medical histories. We encourage readers to verify claims through cited primary sources and to consult their physicians regarding any therapeutic considerations.
How is content reviewed for accuracy?
Every article and resource page undergoes a multi-step editorial review process. Content is drafted with reference to peer-reviewed publications, vetted for factual accuracy against primary source data, and reviewed by at least one additional team member with relevant domain expertise. We maintain a transparent corrections policy and update published material when new evidence warrants revision. For full details, please refer to our Editorial Policy.
How can I contact the editorial team?
Inquiries, corrections, and correspondence may be directed to [email protected]. We review all messages and endeavor to respond within a reasonable timeframe. For additional details, please see our Contact page.
Last updated: March 2026